- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about NRSN
Recent news which mentions NRSN
From Benzinga
This NeuroSense Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Monday
May 12, 2025
From Benzinga
EXCLUSIVE: Nano-Cap NeuroSense Schedules FDA Meeting To Advance Lead Program And Marketing Application Submission
October 28, 2024
From Benzinga
EXCLUSIVE: NeuroSense Therapeutics In Advanced Talks With Several Multi-Billion-Dollar Pharma Companies To Partner Its Lead Drug
August 28, 2024
From Benzinga
Tickers
NRSN
From InvestorPlace
Tickers
NRSN
From InvestorPlace
From InvestorPlace
NeuroSense's (NASDAQ: NRSN) ALS Drug Candidate Shows Promise In Recent Phase 2b Trial; More Milestones To Come In 2024
January 29, 2024
From Benzinga
Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 06, 2023
From Benzinga
US Stocks Higher; Private Payrolls Rise By 103,000 In November
December 06, 2023
From Benzinga
Why SentinelOne Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
December 06, 2023
From Benzinga
From InvestorPlace
Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
December 05, 2023
From Benzinga
Why GitLab Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
December 05, 2023
From Benzinga
From InvestorPlace
From InvestorPlace
Renowned ALS Researcher Confirms The Efficacy Of NeuroSense Therapeutics' Lead Drug Candidate, PrimeC
October 18, 2023
Tickers
NRSN
From Benzinga
Stocks That Hit 52-Week Lows On Friday
September 29, 2023
From Benzinga
From Benzinga
Why Pliant Therapeutics Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket
January 23, 2023
From Benzinga
Why FARO Technologies Shares Are Trading Lower By 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 20, 2023
From Benzinga
Dow Drops 50 Points; Netflix Sales Top Estimates
January 20, 2023
From Benzinga
Why Netflix Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
January 20, 2023
From Benzinga
From InvestorPlace
Dow Drops 150 Points; Crude Oil Up 1%
January 19, 2023
From Benzinga
Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 19, 2023
From Benzinga
Nasdaq Down Over 100 Points; Procter & Gamble Posts In-Line Earnings
January 19, 2023
From Benzinga
Why Is NeuroSense (NRSN) Stock Up 98% Today?
January 19, 2023
From InvestorPlace
Why Investors Are Buying NeuroSense Therapeutics Stock Today
January 19, 2023
Tickers
NRSN
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.